Bioventus Inc. (BVS) News
Follow Bioventus Inc. (BVS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Bioventus Expects 2026 Net Sales of $590 Million to $595 Million
Bioventus expects 2026 net sales of $590 million to $595 million.
EARNINGS | Nov 03, 2026, 03:37 PM UTC
M
Bioventus Cuts Outlook as Third-Quarter Sales Miss Expectations
Bioventus shares fell 11% to $11.75 in after-hours trading Monday after the company cut its outlook and reported third-quarter sales below analyst expectations. Shares closed down 1.3% at $13.15; they had risen 77% year
EARNINGS | Nov 02, 2026, 11:33 PM UTC
M
Bioventus Reports Q3 Adjusted EBITDA of $28.4 Million
Bioventus reported Q3 sales of $142.4 million, versus an IBES estimate of $149.5 million.
EARNINGS | Nov 02, 2026, 09:31 PM UTC
M
Bioventus Sets FY Adjusted EPS Outlook at $0.75
EARNINGS | Nov 02, 2026, 09:23 PM UTC
M
Bioventus Q3 Adjusted EPS USD 0.17 vs. IBES Estimate USD 0.16
EARNINGS | Nov 02, 2026, 09:22 PM UTC
M
Bioventus Q3 Revenue Rises 3% but Misses Estimates
EQUITY | Nov 02, 2026, 09:12 PM UTC
M
Bioventus Reports Third-Quarter Financial Results
Bioventus reported results for the three and nine months ended September 26, 2026.
EQUITY | Nov 02, 2026, 09:08 PM UTC
M
Bioventus to Report Fiscal Q3 2026 Results November 2
Bioventus said it will report its fiscal third-quarter 2026 financial results on November 2, 2026.
EQUITY | Oct 27, 2026, 11:03 AM UTC
L
Bravura Solutions appoints Ian Whiting as non-executive director
Bravura Solutions Limited says it has appointed Mr. Ian Whiting as a non-executive director with immediate effect.
EQUITY | Sep 08, 2026, 06:30 AM UTC
L
Bravura Solutions director shareholding update via restricted share award
Bravura Solutions Limited confirmed a restricted share award under its FY26 Incentive Plan as part of a director/PDMR shareholding update.
EQUITY | Sep 02, 2026, 04:00 PM UTC
L
Bravura Solutions issues correction to annual report
Bravura Solutions has filed a correction to its annual report.
EQUITY | Aug 28, 2026, 07:00 AM UTC
H
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
New On The Block Digital Brands Group, Inc. (NASDAQ: DBGI ), an apparel and e-commerce company, hired Roth Capital Partners as its financial adviser to assist in a strategic review, including a sale or merger. AquaBounty
EARNINGS | Aug 07, 2026, 05:12 PM UTC
L
Bioventus Affirms FY2026 Adj EPS Guidance of $0.75-$0.79 vs $0.78 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $605.756M Est
Bioventus (NASDAQ: BVS ) affirms FY2026 Adj EPS guidance from $0.75-$0.79 to $0.75-$0.79 vs $0.78 analyst estimate. Affirms FY2026 sales outlook from $600.000 million-$610.000 million to $600.000 million-$610.000 million
EARNINGS | Aug 05, 2026, 11:31 AM UTC
L
BVS - Bioventus Reports Second Quarter Financial Results
BVS - Bioventus Reports Second Quarter Financial Results
EARNINGS | Aug 05, 2026, 11:30 AM UTC
L
BVS - Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
BVS - Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
EARNINGS | Jul 29, 2026, 12:31 PM UTC
L
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Bioventus Inc. Insiders Breach their Fiduciary Duti
EQUITY | Jul 03, 2026, 04:24 PM UTC
L
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m
EQUITY | Jul 02, 2026, 09:05 PM UTC